RHEUMATOID ARTHRITIS
RESEARCH STUDY

Have you been diagnosed with rheumatoid arthritis?

A clinical research study is enrolling participants taking methotrexate for a type of early rheumatoid arthritis.

If you have a certain type of early rheumatoid arthritis and are currently taking methotrexate, you may be eligible to participate in the IM101-863 study.

The purpose of this study is to compare 2 investigational drugs. This study will evaluate the efficacy and safety of the study drug abatacept compared with the study drug adalimumab. Study participants will continue to receive methotrexate throughout the study.

You May Qualify if You:

Are 18 years old or older
Have been diagnosed with a certain type of early rheumatoid arthritis
Are receiving treatment with a stable dose of methotrexate

Participants May Receive:

Study medications and examinations at no cost
Reimbursement for time and travel

Please enter your information below so that our study coordinator can contact you:

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid mobile number.

Please enter valid zip code.

Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.